Bonness Enterprises Inc Organon & Co. Transaction History

Bonness Enterprises Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	SELL	$19.27 - $24.63 $40,274 - $51,476	-2,090 Reduced 4.02%	49,860 $1.04 Million
Q1 2022 Apr 25, 2022	BUY	$30.45 - $39.36 $1.58 Million - $2.04 Million	51,950 New	51,950 $1.81 Million
Q1 2022 Apr 08, 2022	SELL	$30.45 - $39.36 $1.58 Million - $2.04 Million	-51,950 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$28.67 - $37.13 $1.3 Million - $1.68 Million	45,200 Added 669.63%	51,950 $1.58 Million
Q3 2021 Oct 12, 2021	SELL	$28.63 - $35.64 $5,726 - $7,128	-200 Reduced 2.88%	6,750 $221,000
Q2 2021 Jul 13, 2021	BUY	$28.45 - $38.0 $197,727 - $264,100	6,950 New	6,950 $210,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bonness Enterprises Inc, based on Form 13F filings with the SEC.

Stay updated on Bonness Enterprises Inc with notifications on news.